No Data
No Data
Cytokinetics Shares Are Trading Higher Amid Rumors the Company May Be Acquired. Additionally, Morgan Stanley Upgraded the Stock From Equal-Weight to Overweight Yesterday.
Express News | Adam Feuerstein Posts On X "Love the Idea of $CYTK Possibly Being Acquired, Hate Rumors on a Friday Before a Holiday."
Cytokinetics Jumps Amid Renewed Takeover Speculation
Cytokinetics Rumor Highlighted in Betaville Alert
Cytokinetics to Announce Fourth Quarter Results on February 27, 2025
MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday